Our poster on the MK057 study on Pembrolizumab for #BCG unresponsive non-muscle invasive bladdercancer #eau18 https://t.co/eVaq2mjeEZ
Our poster on the MK057 study on Pembrolizumab for #BCG unresponsive non-muscle invasive bladdercancer #eau18 https://t.co/eVaq2mjeEZ